# Medroxyprogesterone Acetate

NDC: 67457-887
Generic name: Medroxyprogesterone Acetate
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SUSPENSION
Routes: INTRAMUSCULAR
Marketing started: 20181012

FDA application: ANDA210227

## Active ingredients

- MEDROXYPROGESTERONE ACETATE: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-887"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-887
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60aba812-59eb-4d40-9b6b-d135dca9d36b